ctrl K

Neumora Therapeutics Inc.... (NMRA)

NASDAQ: NMRA · Real-Time Price · USD

0.77

-0.01 (-1.26%)

At close: May 01, 2025, 3:59 PM

Neumora Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	668K	2.7M	1.55M	n/a
Gross Profit	n/a	-668K	-2.7M	-1.55M	n/a
Operating Income	-263.46M	-188.19M	-135.87M	-237.32M	-95.52M
Interest Income	19.93M	16.61M	4.56M	n/a	n/a
Pretax Income	-243.61M	-235.66M	-130.9M	-237.31M	-99.27M
Net Income	-243.79M	-235.93M	-130.9M	-237.31M	-99.27M
Selling & General & Admin	62.54M	44.81M	31.12M	24.55M	8.39M
Research & Development	200.93M	142.72M	104.75M	212.78M	87.13M
Other Expenses	n/a	n/a	405K	11K	-3.75M
Operating Expenses	263.46M	187.53M	135.87M	237.32M	95.52M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	-668K	n/a	n/a	n/a
Cost & Expenses	n/a	188.19M	135.87M	237.32M	95.52M
Income Tax Expense	178K	268K	-4.56M	301.44K	-101.3K
Shares Outstanding (Basic)	159.38M	158.83M	151.95M	151.95M	151.95M
Shares Outstanding (Diluted)	159.38M	158.83M	151.95M	151.95M	151.95M
EPS (Basic)	-1.53	-1.49	-0.86	-1.56	-0.65
EPS (Diluted)	-1.53	-1.49	-0.86	-1.56	-0.65
EBITDA	-242.98M	-187.53M	-135.28M	-236.78M	-95.41M
EBIT	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	n/a	668K	2.7M	1.55M	105K